{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:07:18Z","timestamp":1793657238241,"version":"4.5.1"},"reference-count":22,"publisher":"American Society of Hematology","issue":"15","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,4,13]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>Conditioning is associated with better thymopoiesis, donor B-lymphocyte chimerism, cessation of immunoglobulin therapy, and normal QoL.<\/jats:p>","DOI":"10.1182\/blood-2016-11-748616","type":"journal-article","created":{"date-parts":[[2017,2,16]],"date-time":"2017-02-16T21:00:54Z","timestamp":1487278854000},"page":"2198-2201","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":68,"title":["Long-term outcome of hematopoietic stem cell transplantation for IL2RG\/JAK3 SCID: a cohort report"],"prefix":"10.1182","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6749-1498","authenticated-orcid":false,"given":"Intan Juliana","family":"Abd Hamid","sequence":"first","affiliation":[{"name":"Pediatric Immunodeficiency Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom;"},{"name":"Department of Paediatric Immunology and Hematopoietic Stem Cell Transplantation, Great North Children\u2019s Hospital, Newcastle upon Tyne, United Kingdom;"},{"name":"Regenerative Medicine Cluster, Institut Perubatan and Pergigian Termaju, Universiti Sains Malaysia, Kepala Batas, Malaysia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary A.","family":"Slatter","sequence":"additional","affiliation":[{"name":"Pediatric Immunodeficiency Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom;"},{"name":"Department of Paediatric Immunology and Hematopoietic Stem Cell Transplantation, Great North Children\u2019s Hospital, Newcastle upon Tyne, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"McKendrick","sequence":"additional","affiliation":[{"name":"Department of Health Psychology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Pearce","sequence":"additional","affiliation":[{"name":"Institute of Health and Society, Newcastle University, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Gennery","sequence":"additional","affiliation":[{"name":"Pediatric Immunodeficiency Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom;"},{"name":"Department of Paediatric Immunology and Hematopoietic Stem Cell Transplantation, Great North Children\u2019s Hospital, Newcastle upon Tyne, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"7","key":"2019111903093811800_B1","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/jama.2014.9132","article-title":"Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States [published correction appears in JAMA. 2014;312(20):2169]","volume":"312","author":"Kwan","year":"2014","journal-title":"JAMA"},{"issue":"26","key":"2019111903093811800_B2","doi-asserted-by":"crossref","first-page":"6824","DOI":"10.1182\/blood-2011-06-362533","article-title":"IL-21 is the primary common \u03b3 chain-binding cytokine required for human B-cell differentiation in vivo","volume":"118","author":"Recher","year":"2011","journal-title":"Blood"},{"issue":"3","key":"2019111903093811800_B3","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/1521-4141(200003)30:3<732::AID-IMMU732>3.0.CO;2-L","article-title":"Intrinsic defects of B cell function in X-linked severe combined immunodeficiency","volume":"30","author":"White","year":"2000","journal-title":"Eur J Immunol"},{"issue":"8515","key":"2019111903093811800_B4","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0140-6736(86)90477-0","article-title":"Bone-marrow transplantation for immunodeficiencies and osteopetrosis: European survey, 1968-1985","volume":"2","author":"Fischer","year":"1986","journal-title":"Lancet"},{"issue":"9357","key":"2019111903093811800_B5","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0140-6736(03)12513-5","article-title":"Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99","volume":"361","author":"Antoine","year":"2003","journal-title":"Lancet"},{"issue":"1-3","key":"2019111903093811800_B6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12026-010-8191-9","article-title":"Transplantation of hematopoietic stem cells in human severe combined immunodeficiency: longterm outcomes","volume":"49","author":"Buckley","year":"2011","journal-title":"Immunol Res"},{"issue":"17","key":"2019111903093811800_B7","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.1182\/blood-2008-09-177923","article-title":"Long-term outcome after hematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency","volume":"113","author":"Neven","year":"2009","journal-title":"Blood"},{"issue":"5","key":"2019111903093811800_B8","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1056\/NEJMoa1401177","article-title":"Transplantation outcomes for severe combined immunodeficiency, 2000-2009","volume":"371","author":"Pai","year":"2014","journal-title":"N Engl J Med"},{"issue":"3","key":"2019111903093811800_B9","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jaci.2010.06.015","article-title":"Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better?","volume":"126","author":"Gennery","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"2019111903093811800_B10","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0022-3476(99)70291-X","article-title":"Influence of severe combined immunodeficiency phenotype on the outcome of HLA non-identical, T-cell-depleted bone marrow transplantation: a retrospective European survey from the European group for bone marrow transplantation and the european society for immunodeficiency","volume":"134","author":"Bertrand","year":"1999","journal-title":"J Pediatr"},{"issue":"4","key":"2019111903093811800_B11","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.jaci.2013.01.047","article-title":"B-cell reconstitution for SCID: should a conditioning regimen be used in SCID treatment?","volume":"131","author":"Haddad","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"2019111903093811800_B12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s10875-012-9797-6","article-title":"Post-transplantation B cell function in different molecular types of SCID","volume":"33","author":"Buckley","year":"2013","journal-title":"J Clin Immunol"},{"issue":"2","key":"2019111903093811800_B13","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1182\/blood-2006-01-009241","article-title":"Early determinants of long-term T-cell reconstitution after hematopoietic stem cell transplantation for severe combined immunodeficiency","volume":"108","author":"Borghans","year":"2006","journal-title":"Blood"},{"issue":"10","key":"2019111903093811800_B14","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.1182\/blood-2006-07-029090","article-title":"Long-term T-cell reconstitution after hematopoietic stem-cell transplantation in primary T-cell-immunodeficient patients is associated with myeloid chimerism and possibly the primary disease phenotype","volume":"109","author":"Cavazzana-Calvo","year":"2007","journal-title":"Blood"},{"issue":"2","key":"2019111903093811800_B15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jaci.2007.10.035","article-title":"Long-term immune reconstitution after anti-CD52-treated or anti-CD34-treated hematopoietic stem cell transplantation for severe T-lymphocyte immunodeficiency","volume":"121","author":"Slatter","year":"2008","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"2019111903093811800_B16","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/00005650-200108000-00006","article-title":"PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations","volume":"39","author":"Varni","year":"2001","journal-title":"Med Care"},{"issue":"1","key":"2019111903093811800_B17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1477-7525-3-22","article-title":"Measurement properties of the UK-English version of the Pediatric Quality of Life Inventory 4.0 (PedsQL) generic core scales","volume":"3","author":"Upton","year":"2005","journal-title":"Health Qual Life Outcomes"},{"issue":"11","key":"2019111903093811800_B18","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1182\/blood-2004-12-4837","article-title":"Failure of SCID-X1 gene therapy in older patients","volume":"105","author":"Thrasher","year":"2005","journal-title":"Blood"},{"issue":"16","key":"2019111903093811800_B19","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1182\/blood-2010-10-312082","article-title":"Treosulfan-based conditioning regimens for hematopoietic stem cell transplantation in children with primary immunodeficiency: United Kingdom experience","volume":"117","author":"Slatter","year":"2011","journal-title":"Blood"},{"issue":"12","key":"2019111903093811800_B20","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/bmt.2015.171","article-title":"Treosulfan-based conditioning regimens for allogeneic haematopoietic stem cell transplantation in children with non-malignant diseases","volume":"50","author":"Slatter","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"2019111903093811800_B21","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1182\/blood-2016-03-704015","article-title":"Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience","volume":"128","author":"Morillo-Gutierrez","year":"2016","journal-title":"Blood"},{"issue":"9","key":"2019111903093811800_B22","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1182\/blood-2008-04-151332","article-title":"Cognitive and behavioral abnormalities in children after hematopoietic stem cell transplantation for severe congenital immunodeficiencies","volume":"112","author":"Titman","year":"2008","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/15\/2198\/1400109\/blood748616.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/15\/2198\/1400109\/blood748616.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T03:09:53Z","timestamp":1574132993000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/129\/15\/2198\/36397\/Longterm-outcome-of-hematopoietic-stem-cell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,13]]},"references-count":22,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2017,4,13]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-11-748616","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,13]]}}}